艾媒咨询 | 2025年中国健康体检行业消费行为调查数据

随着人们健康意识的提升和疾病预防需求的增长，健康体检市场正飞速发展。消费者对健康管理的重视推动了体检市场的细分和升级，同时技术进步也带来了更精准的检测手段和更便捷的服务体验。根据全球新经济产业第三方数据挖掘和分析机构iiMedia Research（艾媒咨询）最新发布的《2025年中国健康体检行业消费行为调查数据》数据显示，选择两年一次体检的消费者占比最高，达到39.41%，表明超过三分之一的消费者倾向于以两年为周期进行健康管理，反映出他们对定期体检的重视。与此同时，常规体检项目以60.62%的占比位居首位，凸显了大多数消费者对基础健康检查的高度关注。进一步分析发现，生化及实验室检测（包括血常规、尿常规、生化、肝功、肾功、甲功、血糖等）以61.89%的占比成为最受关注的健康指标，体现了消费者对全面、精准的健康数据的需求，也印证了基础检查在健康管理中的核心地位。艾媒咨询分析师认为，未来，随着健康大数据和人工智能的应用，健康体检市场将朝着更精准、更智能、更普惠的方向发展，成为大健康产业的重要组成部分。
With the improvement of people's health awareness and the growth of disease prevention demand, the health examination market is developing rapidly. Consumers' attention to health management has promoted the segmentation and upgrading of the physical examination market, while technological progress has also brought more accurate detection means and more convenient service experience. According to the latest "Survey data of consumption behavior of China's health check-up industry in 2025" released by iiMedia Research, a third-party data mining and analysis institution in the global new economy industry, the proportion of consumers who choose a biennial physical examination is the highest, reaching 39.41%. It shows that more than one-third of consumers tend to conduct health management on a two-year cycle, reflecting the importance they attach to regular physical examinations. At the same time, routine physical examination items ranked first with 60.62%, highlighting the high attention of most consumers to basic health examination. Further analysis found that biochemical and laboratory tests (including blood routine, urine routine, biochemistry, liver function, kidney function, thyroid function, blood sugar, etc.) accounted for 61.89% of the most concerned health indicators, reflecting consumers' demand for comprehensive and accurate health data, and also confirmed the core position of basic examination in health management. Analysts believe that in the future, with the application of health big data and artificial intelligence, the health physical examination market will develop in a more accurate, smarter and more inclusive direction and become an important part of the big health industry.

艾媒咨询|2020上半年中国网络互助发展专题研究报告

本报告研究涉及企业/品牌/案例：e互助、相互宝。

在国家政策的支持下，中国网络互助行业不断发展，逐渐成为医疗保障的有益补充。2019年中国网络互助行业救助总人数规模超过3万人，行业救助总金额超50亿元。截至2019年年底，中国网络互助覆盖人数达1.5亿人，预计2020年中国网络互助覆盖率达17.8%，2022年网络互助覆盖人数达有望达到3.9亿，覆盖率将达27.8%。通过网络互助平台的对比，结果显示，相较于报销型和综合型平台，给付型和聚焦型平台在人均互助金、获助比例等方面更具优势，e互助综合能力领先各平台。目前没有发现网络互助行业的规模效应，平台会员分摊未来有望保持平稳发展。未来中国网络互助将进入繁荣发展期，有望成为“国民级”产品，专业化运营与风险管控将成平台重点发展方向，行业也将从同质化到募集效率、金额的差异化发展。

With the support of national policies, China's network mutual assistance industry has continued to develop and has gradually become a useful supplement to medical security. In 2019, the total number of people assisted by China's network mutual assistance industry exceeded 30,000, and the total amount of industry assistance exceeded 5 billion yuan. At the end of 2019, the number of people covered by China's network mutual assistance reached 150 million. It is estimated that the coverage rate of China's network mutual assistance will reach 17.8% in 2020, and the number of network mutual assistance coverage is expected to reach 390 million in 2022, with a coverage rate of 27.8%. Through the comparison of network mutual assistance platforms, the results show that, compared with reimbursement and integrated platforms, payment and focused platforms have more advantages in terms of per capita mutual assistance, the proportion of assistance and so on. Besides, the comprehensive ability of “E HUAZHU” leads all platforms. At present, the scale effect of the network mutual assistance industry has not been found, and the platform members are expected to maintain stable spending in the future. In the future, China's network mutual assistance will enter a period of prosperity and development, and it is expected to become a "national-level" product. Professional operation and risk management will become the key development direction of the platforms. The industry will also develop from homogeneity to differentiated development in raising efficiency and amount.

2012-2013年中国移动医疗市场年度报告

本报告是由艾媒咨询行业分析专家领衔撰写，主要分析了该行业的市场规模、发展现状与投资前景，同时对该行业的未来发展作出科学的趋势预测和专业的行业数据分析，帮助客户评估该行业的投资价值。

艾媒咨询|2020年中国互联网医疗行业发展专题研究报告

本报告研究涉及企业/品牌/案例：圆心科技集团，圆心医疗科技，圆心惠保，阿里健康，浙一互联网医院，丁香园。

近年来，中国互联网医疗行业发展迅速，从萌芽期步入到高速发展期。2020年，互联网医疗受新冠疫情影响发展继续加快，5G和人工智能技术逐步落地应用也助推行业规模增长。iiMedia Research（艾媒咨询）数据显示，74.4%的受访网民在疫情期间参与过互联网医疗服务，且认为其能够减轻门诊压力和避免交叉感染的网民占比也超过七成。在互联网医疗主要细分市场中，移动医疗平台借助移动互联网普及和物流水平提高，其品牌认知和市场发展较快，2020年中国移动医疗用户规模将达到6.35亿人，市场规模也将超过520亿元。

In recent years, China Internet medical industry has developed rapidly, from the embryonic stage to high-speed development period. In 2020, the development of Internet medical industry will continue to accelerate under the influence of Covid-19, and the application of 5G and AI technology will also boost the growth of the industry scale. As the data of iiMedia Research showed, 74.4% of the interviewed netizens participated in Internet medical services during the Covid-19 period, and more than 70% netizens believed that it could reduce the pressure of outpatient service and avoid cross infection. In the main market segments of Internet medical industry, mobile medical platforms, with the help of the popularization of mobile Internet and improvement of logistics level, have a rapid brand recognition and market development. In 2020, the user scale of China mobile medical industry will reach 635 million, and the market size will also exceed 52 billion yuan.

艾媒报告 |2019全球及中国大健康产业运行大数据及决策分析报告

本报告研究涉及企业/品牌/案例：恒瑞医药，白云山，111集团，平安好医生，好大夫在线，优健康，春雨医生，微医，丁香医生，和美医疗，北大医疗，PHG,新氧，联合丽格，正广兴家庭医生，强森医疗，微脉，美中嘉和，零氪科技，中有精准医疗，思派网络，普瑞眼科，臻和科技，移宇科技，小鹿医馆，妈咪知道，八百方，京东医药，阿里健康大药房，1药网，一心堂，健一网，好药师，健客网，美丽神器，更美，悦美，美莱整形，伊美尔，丽都整形，芝星整形，欧华美科

大健康产业细分领域的垂直深化，推动了大健康产业格局的不断完善。受政策鼓励和资本推动的影响，2019年，大健康产业在患者服务类领域、医疗服务类领域、医药服务类领域、医疗美容类领域和医疗保健类领域等细分场景快速发展。以恒瑞医药、白云山为代表的传统医药上市公司和以平安好医生、111集团和新氧科技为代表的互联网医疗上市企业各自占据大健康产业领域的一席之地。艾媒商情舆情监测系统数据显示，受2018年和2019年上半年医疗领域负面舆情的影响，大健康产业各上市企业正从低谷平稳回升。艾媒咨询分析师认为，受社会医疗需求和国家政策的推动，大健康产业仍是未来投资的亮点。

The vertical deepening of the large health industry segment has promoted the continuous improvement of the pattern of the big health industry. Influenced by policy encouragement and capital promotion, in 2019, the big health industry developed rapidly in the sub-sectors such as patient service, medical services, medical services, medical and beauty, and health care. The traditional pharmaceutical listed companies represented by Hengrui Medicine and Baiyun Mountain and the Internet medical listed companies represented by Ping An Doctor, 111 Group and New Oxygen Technology each occupy a place in the field of large health industry. According to data from the Aibu Business Intelligence Monitoring System, the listed companies in the big health industry are recovering steadily from the bottom of the market due to the negative public sentiment in the medical field in the first half of 2018 and 2019. Ai Media Consulting analysts believe that the health industry is still the highlight of future investment, driven by social medical needs and national policies.

艾媒咨询｜2022-2023年全球与中国大健康产业运行大数据及决策分析报告

随着人们对健康的关注度和需求度的逐渐上升，大健康产业已经成为全球热点和新的经济增长点。大健康产业顺应了中国经济转型升级、绿色发展的趋势，全球医疗健康产业投融资金额最多集中在2021年，全年达到6846.03亿元，投融资数量最多在2019年，达2044起。

艾媒报告丨2016Q2中国移动医疗健康市场监测报告

iiMedia Research(艾媒咨询)权威发布《2016Q2中国移动医疗健康市场监测报告》，报告显示，2016年底，中国移动医疗健康市场规模预计将会达到74.2亿元，用户规模预计将接近3亿人。

艾媒报告|《2016第一季度中国移动医疗健康市场监测报告》

2016年6月17日，全球领先的移动互联网第三方数据挖掘和分析机构艾媒咨询(iiMediaResearch)独家首发《2016第一季度中国移动医疗健康市场监测报告》。

艾媒咨询：2015-2016中国移动医疗健康市场研究报告

全球领先的移动互联网第三方数据挖掘和整合营销机构iiMedia Research(艾媒咨询)发布了《2015-2016中国移动医疗健康市场研究报告》。放眼全球，在迎来2015年的快速发展后，全球移动医疗健康市场发展有质的进步，服务水平进一步提高，诊疗范围更加扩大，支付手段更加多样。

艾媒咨询：2015Q3中国移动医疗健康市场监测报告

本报告是由艾媒咨询行业分析专家领衔撰写，主要分析了该行业的市场规模、发展现状与投资前景，同时对该行业的未来发展作出科学的趋势预测和专业的行业数据分析，帮助客户评估该行业的投资价值。